Comparison of the Effect of Flexible Dosage of Solifenacin Succinate Between Patients Who Have Frequent Micturition With and Without Urgency
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2016
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 16 Aug 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 16 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2010 Actual patient number (291) added as reported by ClinicalTrials.gov.